Gastroparesis Market Size, Share & Trends | Forecast to 2027

report image

Gastroparesis Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Gastroparesis Type (Idiopathic, Diabetic, Post-Surgical, and Others), Drug Class Type (Prokinetic Agents, Botulinum Toxin Injections, and Antiemetic Agents), and Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Others)

Publication Month: Jan 2021 | Report Code: TIPRE00008992 | No. of Pages: 155 | Category: Pharmaceuticals | Status: Published

The gastroparesis market was valued at US$ 4,338.61 million in 2019 and is projected to reach US$ 6,025.11 millionby 2027; it is expected to grow at a CAGR of 4.3% from 2020 to 2027.

Gastroparesis is a medical condition characterized by the disability of stomach to empty itself of food in the usual way. Damaged nerves such as vagus nerves and muscles associated with gastric motility may also lead to gastroparesis. The condition is commonly observed in diabetic people. Gastroparesis can be classified as diabetic, idiopathic, and post-surgical on the basis of the cause. Apart from these, viral infections, nerve-related diseases, excessive narcotics and several antidepressant consumption, and amyloidosis may also lead to the onset of gastroparesis.

The COVID-19 pandemic has disrupted supply chain of over-the-counter (OTC) and prescription drugs, and this is likely to limit the market growth in the next few quarters. Moreover, the emphasis of health care providers and medical industries on COVID-19 has led to the lowered focus on the diagnosis and treatment for gastroparesis, which is limiting the market growth to a certain extent.

Lucrative Regions for Gastroparesis Market



Lucrative Regions for Gastroparesis Market

Get more information on this report :


Market Insights

Increasing Geriatric Population Accelerating Demand for Gastroparesis Treatment Modalities

Gastric emptying is associated with the coordination among the motor activity of proximal stomach, distal stomach, and duodenum. These internal organs are controlled by the feedback mechanism from neural signals generated through the interaction between nutrients and small intestine. Aging leads to diminished homeostatic regulations of physiologic functions, along with the slowing of gastric emptying. Moreover, it influences motor and sensory functions. In addition, geriatric population is highly vulnerable to gastroparesis due to factors such as the poor oral medication absorption, inadequate appetite regulation, and postprandial glycemia. According to the 2019 revision of World Population Prospects, 1 in 6 people would be aged more than 65 by 2050, with an increase from 1 in 11 in 2019. Furthermore, according to the same study, one in four people in Europe and North America is projected to be aged over 65 by 2050. Also, the number of people with age more than 80 would reach 426 million by 2050 from 143 million in 2019. Thus, the continuous increase in aging population, coupled with the rise in issues associated with gastric emptying among these populations, drives the gastroparesis market growth.

Type-Based Insights

On the basis of type, the gastroparesis market is segmented into idiopathic, diabetic, post-surgical, and others. The idiopathic segment held the largest share of the market in 2019, while the diabetic segment is estimated to register the highest CAGR during the forecast period.

Gastroparesis Market, by Type – 2019 and 2027

Gastroparesis Market, by Type – 2019 and 2027

Get more information on this report :

Drug Class Type-Based Insights

The gastroparesis market, based on drug class type, is segmented into prokinetic agents, antiemetic agents, and botulinum toxin injections. The prokinetic agents segment held the largest market share in 2019 and is estimated to register the highest CAGR during 2020–2027.

Distribution Channel-Based Insights

On the basis of distribution channel, the gastroparesis market is segmented into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment held the largest share of the market in 2019, and the market for the same is estimated to grow at the highest CAGR from 2020 to 2027.

Strategic Insights

Report Coverage - Gastroparesis Market
Report CoverageDetails
Market Size Value inUS$ 4,338.61 Million in 2019
Market Size Value byUS$ 6,025.11 million by 2027
Growth rateCAGR of 4.3% from 2020-2027
Forecast Period2020-2027
Base Year2020
No. of Pages155
No. of Tables84
No. of Charts & Figures72
Historical data availableYes
Segments coveredGastroparesis Type , Drug Class Type , and Distribution Channel
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

The gastroparesis market players have been adopting the strategy of product innovations to cater to dynamic customer demands, which also allows them to maintain their brand name in the global market.

Gastroparesis Market – by Type

  • Idiopathic
  • Diabetic
  • Post-surgical
  • Others

Gastroparesis Market – by Drug Class Type

  • Prokinetic Agents
  • Botulinum Toxin Injections
  • Antiemetic Agents

Gastroparesis Market – by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others 

GastroparesisMarket– by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific(APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South Americaand Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • EVOKE PHARMA
  • Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)
  • Johnson and Johnson Services, Inc.
  • Allergan Plc
  • NEUROGASTRX, INC.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD
  • Pfizer Inc.
  • ANI Pharmaceuticals, Inc.
  • Ipca Laboratories Ltd.
  • Cinrx Pharma, LLC (Cindome Pharma)

Frequently Asked Questions

Gastroparesis is a condition where the stomach cannot empty itself of food in the usual way. Moreover, the damaged nerves such as vagus nerves and muscles associated with gastric motility may also lead to gastroparesis. The condition is substantially observed in the diabetic population. Gastroparesis can be classified as diabetic, idiopathic, and post-surgical on the basis of causes. Apart from these viral infections, nerve-related diseases, excessive consumption of narcotics and some antidepressants, and amyloidosis may also lead to the occurrence of gastroparesis.
The growth of the market is attributed to some key driving factors such as increasing prevalence of diabetes and growing geriatric population.
The gastroparesis market majorly consists of the players such as EVOKE PHARMA, Bausch Health Companies Inc.(Salix Pharmaceuticals, Ltd.), Johnson And Johnson Services, Inc., Allergan Plc, NEUROGASTRX, INC., TEVA PHARMACEUTICAL INDUSTRIES LTD, Pfizer Inc., ANI Pharmaceuticals, Inc., Ipca Laboratories Ltd., And Cinrx Pharma, LLC (Cindome Pharma) amongst others.

The List of Companies - Gastroparesis Market

  1. EVOKE PHARMA
  2. Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)
  3. Johnson and Johnson Services, Inc.
  4. Allergan Plc
  5. NEUROGASTRX, INC.
  6. TEVA PHARMACEUTICAL INDUSTRIES LTD
  7. Pfizer Inc.
  8. ANI Pharmaceuticals, Inc.
  9. Ipca Laboratories Ltd.
  10. Cinrx Pharma, LLC (Cindome Pharma)  
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the gastroparesis market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global gastroparesis market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00008992
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




christmas_festive_offer

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
Pricing
  • $3000 $2700
  • $4550 $4095
  • $6550 $5568
  • $8550 $6840

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount